Studies have shown that the risk of heart disease is higher in this group of women after radiation treatment because it can be difficult to ensure that a sufficient dose of radiation is delivered to the left breast while adequately shielding the heart from exposure. New research shows a woman who holds her breath during radiation pulses can greatly reduce exposure to the heart.
“Radiation therapy is commonly prescribed to patients with breast
cancer following surgery as a component of first-line therapy,” said
first author Harriet Eldredge-Hindy, M.D., a Chief Resident and
researcher in the Department of Radiation Oncology at Thomas Jefferson
University “We wanted to determine how effective breath-hold could be in
shielding the heart from extraneous radiation exposure during treatment
of the left breast.”
Recent studies have shown women with cancer in the left breast are at higher risk of heart disease, and that the risk increases proportionately with the dose of radiation the heart is exposed to during treatment. A number of techniques have been developed to reduce exposure to the heart including prone positioning (lying flat on the belly on a bed that only exposes the left breast), intensity-modulated radiation therapy (IMRT), and accelerated partial breast irradiation. The breath-hold technique allows doctors to monitor a patient’s breath for the position that shifts the heart out of the range of the radiation beam.
In the largest prospective study to date, following women for 8 years post treatment, 81 women were asked to hold their breath during radiation treatment for breast cancer– a process that was repeated until therapeutic dose was reached. The researchers found that patients capable of holding their breath over the course of treatment had a 90 percent disease-free survival, and a 96 percent overall survival, with a median reduction in radiation dose to the heart of 62 percent. The findings were published online this week in the journal Practical Radiation Oncology.
“Given that this technique helps to shield the heart during radiation treatment for breast cancer,” said Rani Anne, M.D., Associate Professor of Radiation Oncology at Thomas Jefferson University and senior author on the study, “we routinely offer breast cancer treatment with the breath hold technique at Jefferson.”
Additional work recently presented at the 2014 American Society for Radiation Oncology in San Francisco carried the work further in order to determine whether protection from the additional radiation dose in fact translated to a reduction in ischemic heart disease. Dr. Anne, together with first author Harriet Eldredge-Hindy, M.D., showed that this same cohort of patients will likely have a reduced risk of ischemic heart disease after 10 years. The study showed that patients who held their breath during radiation therapy had only a 1.4 percent rate of ischemic heart disease after 8 years of follow up and an estimated rate of 3.6 percent after 10 years.
For more information, contact Edyta Zielinska, 215-955-5291, edyta.zielinska@jefferson.edu.
About Jefferson — Health is all we do.
Thomas Jefferson University, Thomas Jefferson University Hospitals and Jefferson University Physicians are partners in providing the highest-quality, compassionate clinical care for patients, educating the health professionals of tomorrow, and discovering new treatments and therapies that will define the future of healthcare. Thomas Jefferson University enrolls more than 3,600 future physicians, scientists and healthcare professionals in the Sidney Kimmel Medical College (SKMC); Jefferson Schools of Health Professions, Nursing, Pharmacy, Population Health; and the Graduate School of Biomedical Sciences, and is home of the National Cancer Institute (NCI)-designated Sidney Kimmel Cancer Center. Jefferson University Physicians is a multi-specialty physician practice consisting of over 650 SKMC full-time faculty. Thomas Jefferson University Hospitals is the largest freestanding academic medical center in Philadelphia. Services are provided at five locations — Thomas Jefferson University Hospital and Jefferson Hospital for Neuroscience in Center City Philadelphia; Methodist Hospital in South Philadelphia; Jefferson at the Navy Yard; and Jefferson at Voorhees in South Jersey.
Article reference: H. Eldredge-Hindy, et al., “Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial,” Practical Radiation Oncology, DOI: http://dx.doi.org/10.1016/j.prro.2014.06.004, 2014
Recent studies have shown women with cancer in the left breast are at higher risk of heart disease, and that the risk increases proportionately with the dose of radiation the heart is exposed to during treatment. A number of techniques have been developed to reduce exposure to the heart including prone positioning (lying flat on the belly on a bed that only exposes the left breast), intensity-modulated radiation therapy (IMRT), and accelerated partial breast irradiation. The breath-hold technique allows doctors to monitor a patient’s breath for the position that shifts the heart out of the range of the radiation beam.
In the largest prospective study to date, following women for 8 years post treatment, 81 women were asked to hold their breath during radiation treatment for breast cancer– a process that was repeated until therapeutic dose was reached. The researchers found that patients capable of holding their breath over the course of treatment had a 90 percent disease-free survival, and a 96 percent overall survival, with a median reduction in radiation dose to the heart of 62 percent. The findings were published online this week in the journal Practical Radiation Oncology.
“Given that this technique helps to shield the heart during radiation treatment for breast cancer,” said Rani Anne, M.D., Associate Professor of Radiation Oncology at Thomas Jefferson University and senior author on the study, “we routinely offer breast cancer treatment with the breath hold technique at Jefferson.”
Additional work recently presented at the 2014 American Society for Radiation Oncology in San Francisco carried the work further in order to determine whether protection from the additional radiation dose in fact translated to a reduction in ischemic heart disease. Dr. Anne, together with first author Harriet Eldredge-Hindy, M.D., showed that this same cohort of patients will likely have a reduced risk of ischemic heart disease after 10 years. The study showed that patients who held their breath during radiation therapy had only a 1.4 percent rate of ischemic heart disease after 8 years of follow up and an estimated rate of 3.6 percent after 10 years.
For more information, contact Edyta Zielinska, 215-955-5291, edyta.zielinska@jefferson.edu.
About Jefferson — Health is all we do.
Thomas Jefferson University, Thomas Jefferson University Hospitals and Jefferson University Physicians are partners in providing the highest-quality, compassionate clinical care for patients, educating the health professionals of tomorrow, and discovering new treatments and therapies that will define the future of healthcare. Thomas Jefferson University enrolls more than 3,600 future physicians, scientists and healthcare professionals in the Sidney Kimmel Medical College (SKMC); Jefferson Schools of Health Professions, Nursing, Pharmacy, Population Health; and the Graduate School of Biomedical Sciences, and is home of the National Cancer Institute (NCI)-designated Sidney Kimmel Cancer Center. Jefferson University Physicians is a multi-specialty physician practice consisting of over 650 SKMC full-time faculty. Thomas Jefferson University Hospitals is the largest freestanding academic medical center in Philadelphia. Services are provided at five locations — Thomas Jefferson University Hospital and Jefferson Hospital for Neuroscience in Center City Philadelphia; Methodist Hospital in South Philadelphia; Jefferson at the Navy Yard; and Jefferson at Voorhees in South Jersey.
Article reference: H. Eldredge-Hindy, et al., “Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial,” Practical Radiation Oncology, DOI: http://dx.doi.org/10.1016/j.prro.2014.06.004, 2014